InvestorsHub Logo
Followers 467
Posts 26931
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 215

Friday, 10/21/2011 11:07:57 AM

Friday, October 21, 2011 11:07:57 AM

Post# of 392
Vanda Pharmaceuticals, Inc. (VNDA) – The value in this company is purely in its growth prospects. Trading near its 52-week low, and having missed earnings in a release in early August, this may be an excellent buying opportunity if the company is able to turn itself around. Furthermore, given the attractiveness of its lead drug in the effective treatment of schizophrenia, the company may become an acquisition target. With a microcap market capitalization and average daily trading volume around 150,000 shares per day, investors should take care in this name.

http://seekingalpha.com/article/293435-6-deeply-undervalued-biotech-companies?source=yahoo


surf's up......crikey



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VNDA News